The lymphotropic papovavirus (LPV)-specific mRNAs were translated in vitro in rabbit reticulocyte lysates. The specific products were 84,000-dalton (84K), 41K, 35K, and 26K proteins. Immunoprecipitation with anti-LPV hamster sera and analysis of partially purified LPV virions showed that the last three proteins were the LPV capsid proteins, and we designated the 41K, 35K, and 26K proteins VP1 (major capsid protein), VP2, and VP3, respectively. Several characteristics, such as the small amount of mRNA for the 84K protein at late stages of infection, its absence from partially purified virus preparations, no common tryptic peptides between the 84K and 41K proteins, and the pattern of in vivo phosphorylation, suggest that the 84K protein is not a simple dimer of the 41K protein. Normal human sera and sera from certain leukemic patients positive for antibody to LPV viral antigens immunoprecipitated the 41K protein.
A lymphotropic papovavirus (LPV) was recently isolated from a lymphoblastoid cell line derived from an African green monkey by zur Hauzen and Gissmann (19) . This virus grows only in continuous lines of B-lymphoblasts of monkey or human origin (1, 2, 16) . The size of the virus and the molecular weight of the viral DNA conform to those of other members of the polyoma virus genus. Since it possesses the common antigen shared by all members of the polyoma virus genus (16, 19) , it is clearly a novel member of this genus. Our serological studies (16) and those of Brade et al. (1, 2) showed that about 25 to 30% of humans have antibody against LPV, suggesting that a related, as yet unidentified lymphotropic virus also exists in humans.
In this communication, we examined the LPV-coded proteins by in vitro translation of the specific mRNA for LPV and by immunoprecipitation with sera from hamsters immunized with LPV.
The LPV-susceptible B-lymphoblastoid cell line Tl-1 (5) was obtained from Y. Hinuma (Kyoto University, Japan) and maintained in RPMI 1640 medium supplemented with 5% newborn calf serum. Infection of Tl-1 cells was done as previously described (16) .
Polyadenylate-containing RNA was prepared from LPV-infected and mock-infected Tl-1 cells (12) at 5 days postinfection. At this time, 50% of the cells were positive for viral antigen by the fluorescent antibody (FA) test. The LPV-specific mRNAs were selected by hybridization with plasmid DNA containing LPV DNA (16) on nitrocellulose filters in buffer containing 65% formamide, 10 mM PIPES (1,4-piperazinediethanesulfonic acid) (pH 6.4), and 0.4 M NaCl at 50°C. Under these stringent conditions, the minimum size of base homology required for hybridization was approximately 50 nucleotides in a row (11) . After being washed extensively with 0.15 M NaCl-0.015 M sodium citrate-0.5% sodium dodecyl sulfate (SDS) and twice with 2.0 mM EDTA at 60°C, the specifically hybridized mRNAs were eluted and translated in vitro in reticulocyte lysates containing [35S]methionine (New England Nuclear Corp.). The translated products were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE). The LPV-specific proteins, which were not detected in the translated product from mock-infected cells, were 84,000-dalton (84K), 41K, 35K, and 26K proteins (Fig. 1, lanes 1 and 2) . In addition, 23K and 13K proteins were detected. However, it was not clear whether these two proteins were LPVspecific primary translated products, because proteins with similar molecular weights were detected in the translated products from mockinfected cells (Fig. 1, lane 2) . Since these background proteins could be translated without adding exogenous mRNA, the mRNA for these proteins must have been derived endogenously from the reticulocyte lysate. When partially purified LPV virions were disrupted by SDS and mercaptoethanol and analyzed by SDS-PAGE, the major and minor stainable bands were 41K, 35K, and 26K (data not shown). Therefore, the 41K, 35K, and 26K proteins are most likely the viral capsid proteins, corresponding in size to those found in other polyoma viruses (10, 17) . We therefore designated these proteins VP1 (major capsid protein), VP2, and VP3, respectively.
For detection of in vivo-synthesized LPVcoded proteins, LPV-infected TI-1 cells were labeled with [35S]methionine (200 uCi/ml) or 32p; (0.5 mCi/ml) for 3 h at 5 days postinfection. Cellular extracts from infected cells were prepared and immunoprecipitated with anti-LPV and normal hamster sera as described earlier (15) . Anti-LPV serum immunoprecipitated the major capsid proteins (41K) in the cellular extracts from LPV-infected Tl-1 cells (Fig. 1, lane  5 ) and in the in vitro-translated products (lane 3). However, the anti-LPV hamster serum did not immunoprecipitate the 35K (VP2) or 26K (VP3) protein very well in either the in vitro-translated products or the cellular extracts. This may be due either to the low titer of this serum against 35K (VP2) and 26K (VP3) or to the smaller amounts of these proteins produced in infected cells. This antibody also reacted with several other proteins in the cellular extract (Fig. 1, lane  5 ), but these proteins were not characterized further. The relationship between the 56K protein (see Fig. 4, lane 3) and the cellular p53 protein, which tends to associate with papovavirus early gene products (8) , is under further study.
The amount of 84K protein found in the in vitro-translated products was very small, probably due to the small amount of mRNA specific for the 84K protein at late stages of infection (Fig. 1, lane 1) . However, after immunoprecipitation with LPV antiserum the 84K protein was clearly seen (lane 3). Furthermore, the relative amounts of the 84K and 41K proteins immunoprecipitated were the same as those found in in vivo-labeled cellular extracts (lane 5). Why LPV antiserum precipitated the 84K protein efficiently is not clear at present. The 84K protein was not detected in the extracts from mock-infected cells (see Fig. 4 , land 1), suggesting that the 84K protein is a virus-coded product. This protein was not detected in partially purified virus (data not shown). Fingerprint analysis showed that the 84K protein does not have the same tryptic peptides the 41K protein (Fig. 2) . With extracts of LPV-infected cells labeled with 32p;, phosphorylated 84K protein was immunoprecipitated by the hamster anti-LPV serum, but phosphorylated 41K protein was not detected (Fig. 3) . These results suggest that the 84K protein is not a simple dimer of the 41K protein, as was reported for polyoma virus (17) . It has been reported that adult hamsters injected with purified polyoma virions produce antibody against both capsid proteins and T-antigens (3) . It is therefore possible that inoculation of hamsters with LPV resulted in the production of LPV anti-T as well as anti-viral antibody, and that the 84K protein may be the LPV T-antigen precipitated by this type of serum. Definitive proof that the 84K protein is the LPV T-antigen must await the production of LPV tumors in suitable hosts.
The band of in vivo-phosphorylated 84K protein was cut from the gels, electroeluted, and hydrolyzed in 6 N HCI for 2 h at 105°C (13) . The resultant phosphoamino acids were analyzed on thin-layer plates in two dimensions (7) . The phosphoacceptor amino acids in the in vivophosphorylated 84K protein were serine and threonine, at a ratio of about 4:1 (data not shown). This value was almost the same as that reported for simian virus 40 T-antigen (18) . No phosphotyrosine was detected.
In previous studies (1, 16) Fingerprint analysis of tryptic peptides derived from the 84K and 41 K proteins. The 84K (A) and 41K (B) proteins were eluted from the appropriate gel slices cut from SDS-polyacrylamide gels and oxidized with performic acid for 3 h at 0°C. After lyophilization, proteins were digested with 10 ,ug of tolylsulfonyl phenylalanyl chloromethyl ketone-trypsin (Worthington Diagnostics) at 37°C for 2 h; another 10 ,ug was then added, and the digestion was continued for another 3 h. The tryptic digests were analyzed on a thinlayer plate two dimensionally as described earlier (14) . then tested. Two strongly positive sera from patients with acute lymphocytic leukemia and three positive sera from normal adults as well as a negative serum were inclined in the test. The major band immunoprecipitated by the positive sera was the 41K protein (Fig. 4, lanes 5-9) ; however, the amount of 41K protein immunoprecipitated was about one fifth of that observed with anti-LPV hamster sera (lane 3). A trace amount of 41K protein was detected with the FA-negative serum (lane 10). The amount of 41K protein precipitated by the strongly positive sera from leukemia patients (lanes 5 and 6) was about two to three times greater than that precipitated by the positive normal human sera (lanes 7, 8, and 9). After prolonged exposure of the dried gel, a trace amount of 84K protein was also detected with the serum from one of the leukemic patients (data not shown). These results confirm the findings of Brade et al. (1), who reported that LPV-positive sera immunoprecipitated a 40K protein from LPV-infected cells.
The LPV-specific mRNAs at late stages of infection were selected and translated in vitro. The virus-specific products were 84K, 41K, 35K, and 26K proteins. In addition, 23K and 19K proteins were translated in vitro. However, it is not clear at present whether these proteins are primary virus-coded proteins (e.g., low-molecular-weight early gene products) or degradation products of the high-molecular-weight proteins, because fairly high backgrounds were observed in the same region derived from the translated product of the endogenous mRNA in reticulocyte lysates. Thus, for precise identification of the early gene products, it will be necessary to determine and map the early and late RNAs and to translate the mRNAs hybridized to the specific DNA fragments corresponding to the early region. The capsid proteins of LPV that we have described were slightly smaller than those reported for other polyoma viruses (4, 6, 9) . Besides these structural proteins, we also detected an 84K protein which may be an early gene product, possibly one of the T-antigens of LPV. It was smaller than the large T-antigens of simian virus 40 and polyoma virus, but this can perhaps be explained on the basis of the smaller 5.1-kilobase genome of LPV (16) . Definitive evidence for the size and properties of the LPV T-antigens must await the production of LPV Tantiserum.
The ability of LPV-positive human sera to immunoprecipitate the major polypeptide of LPV, the 41K protein, indicates a close relationship between the putative human LPV and the African green monkey LPV. This is further substantiated by neutralization tests (1; unpublished data), which have shown that FA-positive human sera neutralize the infectivity of LPV.
